Incyte Corp Stock Target Price and Analyst Consensus

INCY -  USA Stock  

USD 64.75  0.81  1.24%

The current analyst and expert consensus on Incyte Corp is Buy with 6 hold recommendations. The current projected Incyte Corp target price consensus is 88.82 with 11 analyst opinions. One of the most common ways Incyte Corp analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Incyte Corp vendors, executives, and/or customers. Incyte Corp recommendation module provides expert sentiment on the projected Incyte Corp target price to derive its highest and lowest estimates based on target price standard deviation of 12.106. Please see Macroaxis Advice on Incyte Corp to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Incyte Analyst Recommendations 

 
Refresh
Gross Profit is likely to rise to about 2.7 B in 2021, whereas Profit Margin is likely to drop (0.12)  in 2021. Incyte Corp Inventory is fairly stable at the moment as compared to the past year. Incyte Corp reported Inventory of 35.97 Million in 2020. Investments is likely to rise to about 551 M in 2021, whereas Accumulated Other Comprehensive Income is likely to drop (15.8 M) in 2021.

Incyte Corp Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Incyte target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Incyte target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions13
Lowered Outlook1
Raized Outlook0
Buy
Most Incyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Incyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Incyte Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Incyte Corp Target Price Projection

Incyte Corp's current and average target prices are 64.75 and 88.82, respectively. The current price of Incyte Corp is the price at which Incyte Corp is currently trading. On the other hand, Incyte Corp's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Incyte Corp Market Quote on 18th of October 2021

Low Price64.63Odds
High Price65.53Odds

64.75

Target Price

Analyst Consensus On Incyte Corp Target Price

Low Estimate66.0Odds
High Estimate110.0Odds
Number of Analysts11
Standard Deviation12.106

88.818

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Incyte Corp and the information provided on this page.

Incyte Corp Analyst Ratings

Incyte Corp's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Incyte Corp stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Incyte Corp's financials, market performance, and future outlook by experienced professionals. Incyte Corp's historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Incyte Corp Target Price Projections

Incyte Corp's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Incyte Corp and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Incyte depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Incyte Corp
 2019 2020 2021 (projected)
Long Term Debt to Equity0.01230.01250.0128
Interest Coverage216.71195.04210.44

Additional Incyte Corp Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Incyte Corp is a key component of Incyte Corp valuation and have some predictive power on the future returns of a Incyte Corp.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Incyte Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Incyte Corp in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
64.2065.7767.34
Details
Intrinsic
Valuation
LowReal ValueHigh
59.0073.9175.48
Details
Naive
Forecast
LowNext ValueHigh
66.0067.5769.14
Details
Earnings
Estimates (6)
LowProjected EPSHigh
2.012.252.68
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Incyte Corp. Your research has to be compared to or analyzed against Incyte Corp's peers to derive any actionable benefits. When done correctly, Incyte Corp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Incyte Corp.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Please see Macroaxis Advice on Incyte Corp to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The data published in Incyte Corp's official financial statements usually reflect Incyte Corp's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Incyte Corp. For example, before you start analyzing numbers published by Incyte accountants, it's critical to develop an understanding of what Incyte Corp's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Incyte Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Incyte Corp's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Incyte Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Incyte Corp. Please utilize our Beneish M Score to check the likelihood of Incyte Corp's management to manipulate its earnings.